04/03/2024
3:29 PM | Carlyle Group Inc. (Filer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Filer)
| Form PRE 14A | |
03/29/2024
3:30 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Filed by)
Q32 Bio Inc. (Subject)
Q32 Bio Inc. (Subject)
| Form SC 13G | |
03/05/2024
5:43 PM | Carlyle Group Inc. (Issuer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Issuer)
SCHWARTZ HARVEY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
5:02 PM | Carlyle Group Inc. (Issuer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Issuer)
SCHWARTZ HARVEY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:14 PM | Carlyle Group Inc. (Subject)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Subject)
Larson Bruce M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
5:00 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Filed by)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics, Inc. (Subject)
| Form SC 13D/A | |
02/12/2024
5:23 PM | Abingworth Bioventures VII LP (Reporting)
Abingworth LLP (Reporting)
Carlyle Genesis UK LLC (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Reporting)
Carlyle Holdings I GP Inc. (Reporting)
Carlyle Holdings I GP Sub L.L.C. (Reporting)
Carlyle Holdings I L.P. (Reporting)
Carlyle Investment Management LLC (Reporting)
CG Subsidiary Holdings L.L.C. (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics, Inc. (Issuer)
TC Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/12/2024
4:45 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Filed by)
MKS INSTRUMENTS INC (Subject)
| Form SC 13G/A | |
02/12/2024
4:46 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Filed by)
ZoomInfo Technologies Inc. (Subject)
| Form SC 13G/A | |
02/12/2024
10:22 AM | Carlyle Group Inc. (Subject)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G/A | |
02/08/2024
8:23 PM | Carlyle Group Inc. (Issuer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Issuer)
Redett John C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
8:25 PM | Carlyle Group Inc. (Issuer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Issuer)
Ferguson Jeffrey W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
8:17 PM | Carlyle Group Inc. (Issuer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Issuer)
Finn Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
8:19 PM | Andrews Charles Elliott Jr. (Reporting)
Carlyle Group Inc. (Issuer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
8:14 PM | Carlyle Group Inc. (Issuer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Issuer)
Finn Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
8:19 PM | Carlyle Group Inc. (Issuer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Issuer)
Ferguson Jeffrey W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:44 PM | Carlyle Group Inc. (Filer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Filer)
| Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers | |
01/03/2024
3:15 PM | Carlyle Group Inc. (Reporting)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Reporting)
Carlyle Holdings I GP Inc. (Reporting)
Carlyle Holdings I GP Sub L.L.C. (Reporting)
Carlyle Holdings I L.P. (Reporting)
Carlyle Partners VII S1 Holdings, L.P. (Reporting)
CG Subsidiary Holdings L.L.C. (Reporting)
CommScope Holding Company, Inc. (Issuer)
TC Group Sub L.P. (Reporting)
TC Group VII S1, L.L.C. (Reporting)
TC Group VII S1, L.P. (Reporting)
TC Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
3:15 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Filed by)
CommScope Holding Company, Inc. (Subject)
| Form SC 13D/A | |
12/19/2023
4:01 PM | Carlyle Group Inc. (Issuer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Issuer)
SCHWARTZ HARVEY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
4:22 PM | Carlyle Group Inc. (Issuer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Issuer)
SCHWARTZ HARVEY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
4:23 PM | Carlyle Group Inc. (Filer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/03/2023
3:36 PM | Carlyle Group Inc. (Filer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Filer)
| Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers | |
10/16/2023
3:30 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Filed by)
SOLENO THERAPEUTICS INC (Subject)
| Form SC 13D/A | |
10/02/2023
6:54 PM | Abingworth Bioventures VII LP (Reporting)
Abingworth LLP (Reporting)
Carlyle Genesis UK LLC (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Reporting)
Carlyle Holdings I GP Inc. (Reporting)
Carlyle Holdings I GP Sub L.L.C. (Reporting)
Carlyle Holdings I L.P. (Reporting)
Carlyle Investment Management LLC (Reporting)
CG Subsidiary Holdings L.L.C. (Reporting)
SOLENO THERAPEUTICS INC (Issuer)
TC Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2023
4:18 PM | Carlyle Group Inc. (Issuer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Issuer)
Redett John C. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/02/2023
3:30 PM | Carlyle Group Inc. (Reporting)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Reporting)
Carlyle Holdings I GP Inc. (Reporting)
Carlyle Holdings I GP Sub L.L.C. (Reporting)
Carlyle Holdings I L.P. (Reporting)
Carlyle Partners VII S1 Holdings, L.P. (Reporting)
CG Subsidiary Holdings L.L.C. (Reporting)
CommScope Holding Company, Inc. (Issuer)
TC Group Sub L.P. (Reporting)
TC Group VII S1, L.L.C. (Reporting)
TC Group VII S1, L.P. (Reporting)
TC Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
3:22 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Filed by)
Complete Solaria, Inc. (Subject)
Complete Solaria, Inc. (Subject)
Complete Solaria, Inc. (Subject)
| Form SC 13G | |
09/14/2023
3:05 PM | Carlyle Credit Income Fund (Issuer)
Carlyle Group Inc. (Reporting)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Reporting)
Carlyle Holdings I GP Inc. (Reporting)
Carlyle Holdings I GP Sub L.L.C. (Reporting)
Carlyle Holdings I L.P. (Reporting)
CG Subsidiary Holdings L.L.C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
3:05 PM | Carlyle Credit Income Fund (Subject)
Carlyle Group Inc. (Filed by)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Filed by)
| Form SC 13D/A | |
08/30/2023
4:33 PM | Carlyle Credit Income Fund (Issuer)
Carlyle Group Inc. (Reporting)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Reporting)
Carlyle Holdings I GP Inc. (Reporting)
Carlyle Holdings I GP Sub L.L.C. (Reporting)
Carlyle Holdings I L.P. (Reporting)
CG Subsidiary Holdings L.L.C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2023
4:19 PM | Carlyle Credit Income Fund (Subject)
Carlyle Group Inc. (Filed by)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Filed by)
| Form SC 13D/A | |
08/25/2023
5:56 PM | Carlyle Group Inc. (Issuer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Issuer)
SCHWARTZ HARVEY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
3:15 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Filed by)
SOLENO THERAPEUTICS INC (Subject)
| Form SC 13D/A | |
08/18/2023
3:16 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Filed by)
eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
| Form SC 13D/A | |
08/04/2023
3:33 PM | Carlyle Group Inc. (Filer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Filer)
| Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers | |
08/03/2023
5:08 PM | Carlyle Group Inc. (Issuer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Issuer)
Ferguson Jeffrey W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
5:09 PM | Andrews Charles Elliott Jr. (Reporting)
Carlyle Group Inc. (Issuer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
5:12 PM | Carlyle Group Inc. (Issuer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Issuer)
Larson Bruce M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
5:13 PM | Buser Curtis L. (Reporting)
Carlyle Group Inc. (Issuer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
5:14 PM | Carlyle Group Inc. (Issuer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Issuer)
Finn Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad) Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide |
08/02/2023
4:19 PM | Buser Curtis L. (Reporting)
Carlyle Group Inc. (Subject)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2023
4:21 PM | Carlyle Group Inc. (Subject)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Subject)
Larson Bruce M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2023
4:23 PM | Carlyle Group Inc. (Subject)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Subject)
Finn Christopher (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2023
4:25 PM | Carlyle Group Inc. (Subject)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Subject)
Ferguson Jeffrey W. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2023
3:40 PM | Carlyle Credit Income Fund (Subject)
Carlyle Group Inc. (Filed by)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Filed by)
| Form SC 13D/A | |
06/20/2023
6:06 AM | Carlyle Group Inc. (Filer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
3:22 PM | Carlyle Group Inc. (Filer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/25/2023
5:20 PM | Carlyle Group Inc. (Issuer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Issuer)
SCHWARTZ HARVEY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
3:30 PM | Abingworth LLP (Reporting)
Carlyle Genesis UK LLC (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Reporting)
Carlyle Holdings I GP Inc. (Reporting)
Carlyle Holdings I GP Sub L.L.C. (Reporting)
Carlyle Holdings I L.P. (Reporting)
Carlyle Investment Management LLC (Reporting)
CG Subsidiary Holdings L.L.C. (Reporting)
SOLENO THERAPEUTICS INC (Issuer)
TC Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
3:32 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Filed by)
SOLENO THERAPEUTICS INC (Subject)
| Form SC 13D/A | |
05/09/2023
3:31 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Filed by)
Reneo Pharmaceuticals, Inc. (Subject)
| Form SC 13D/A | |
05/03/2023
4:16 PM | Carlyle Group Inc. (Issuer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Issuer)
HANCE JAMES H JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/26/2023
6:01 AM | Carlyle Group Inc. (Filer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2023
6:02 AM | Carlyle Group Inc. (Filer)
Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (Filer)
| Form DEFA14A | |
